CL vs CVKD · P/E 34, rev $10.69B vs $20.2M cap
Colgate-Palmolive Company (CL) versus Cadrenal Therapeutics, Inc. Common Stock (CVKD) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CVKD does not have a complete income-statement cache yet.
CL currently screens at market cap $70.88B and trailing P/E 34.3. CVKD currently screens at market cap $20.2M.
Not investment advice. Open the CL and CVKD stock pages for the full models.
Not investment advice.